Adriamycin can be used to treat early-stage or node-positive breast cancer, HER2-positive breast cancer, and metastatic disease. Adriamycin is sometimes combined with cytoxan and/or 5-fluorouracil to make a cocktail of breast-cancer fighting chemotherapy drugs.